医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DJO Surgical, a DJO Global Company, Announces the First Match Point System™ Shoulder Surgeries

2013年10月31日 PM08:55
このエントリーをはてなブックマークに追加


 

SAN DIEGO

DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the first surgical uses of its Match Point System™ patient-specific shoulder instrumentation in Reverse® Shoulder System cases in Sydney, Australia, and in Fort Lauderdale, FL.

In collaboration with Materialise, a leader in patient-specific instrumentation and innovative software solutions, the Match Point System™ was developed to provide advanced pre-operative surgical planning and patient-customized drill guides to accommodate a reverse or total shoulder arthroplasty procedure. The Match Point System employs Materialise’s proven SurgiCase® Connect software to create CT-based pre-operative case plans for surgeons to template and prepare for their reverse shoulder arthroplasty surgeries using the DJO Surgical Reverse® or Turon™ Shoulder Systems. Upon review and plan approval, the surgeon is provided with an ergonomically-designed drill guide that is customized to the patient’s unique glenoid anatomy, enabling greater accuracy in implant positioning.

“With the increased patient demand for total and reverse shoulder replacements, surgeons are demanding more in terms of improved instrumentation, planning tools, and techniques for their shoulder cases,” said Bryan Monroe, Senior Vice President and General Manager of DJO Surgical. “The Match Point System is well-suited to address these needs. Our strategic partnership with Materialise has been great; together, we are helping the surgeon to facilitate each patient’s return to normal activity.”

Dr. Jonathan Levy (Holy Cross Hospital, Fort Lauderdale, FL), who performed the first Match Point System surgery in the US, stated, “I am excited about this technology and its impact on shoulder arthroplasty. It will revolutionize our approach to pre-operative planning and our ability to accurately execute the surgical procedure even in the most challenging of cases.”

DJO is combining the new Match Point System with the clinical success of the Reverse Shoulder Prosthesis and Turon Modular Total Shoulder System along with a best-in-class medical education program for shoulder arthroplasty. The Match Point System is CE Marked and has also received FDA 510k clearance. The Match Point System is the latest addition to DJO Surgical’s Shoulder Solutions.

About DJO Global

DJO Global is a leading global developer, manufacturer and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health and pain management. The Company’s products address the continuum of patient care from injury prevention to rehabilitation after surgery, injury or from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. In addition, many of the Company’s medical devices and related accessories are used by athletes and patients for injury prevention and at-home physical therapy treatment. The Company’s product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management and physical therapy products. The Company’s surgical division offers a comprehensive suite of reconstructive joint products for the hip, knee and shoulder. DJO Global’s products are marketed under a portfolio of brands including Aircast®, Chattanooga, CMF™, Compex®, DonJoy®, Empi®, ProCare®, DJO® Surgical, Dr. Comfort®, Bell-Horn® and Exos™. For additional information on the Company, please visit www.DJOglobal.com.

CONTACT

DJO Global, Inc.
Matt Simons, 760-734-5548
SVP Business
Development and Investor Relations
matt.simons@DJOglobal.com

同じカテゴリーの記事 

  • Poxel to Report Its 2023 Annual Results by the End of April 2024
  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表
  • Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
  • 领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告